Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medical cannabis effects on quality of life in adults with cancer
RBR-9zvptxgRecruiting
- Sponsor
- Federal University of São Paulo
- Start
- Jan 2023
- Countries
- 1
01
Overview
Open-label, single-arm trial of medical cannabis in anxiety disorder and major depressive disorder (MDD), sponsored by Federal University of São Paulo. Primary endpoints: Quality of life, Depression symptoms and 1 more. Started Jan 2023; status: recruiting.
02
Drugs
medical cannabis
03
Conditions
anxiety disordermajor depressive disorder (MDD)
Beyond the preview
Go deeper on RBR-9zvptxg.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-9zvptxg.